Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.
The Journal Of Clinical Investigation
Jin, Nan N; Keam, Bhumsuk B; Cho, Janice J; Lee, Michelle J MJ; Kim, Hye Ryun HR; Torosyan, Hayarpi H; Jura, Natalia N; Ng, Patrick Ks PK; Mills, Gordon B GB; Li, Hua H; Zeng, Yan Y; Barbash, Zohar Z; Tarcic, Gabi G; Kang, Hyunseok H; Bauman, Julie E JE; Kim, Mi-Ok MO; VanLandingham, Nathan K NK; Swaney, Danielle L DL; Krogan, Nevan J NJ; Johnson, Daniel E DE; Grandis, Jennifer R JR
Spatially interacting phosphorylation sites and mutations in cancer.
Nature Communications
Huang, Kuan-Lin KL; Scott, Adam D AD; Zhou, Daniel Cui DC; Wang, Liang-Bo LB; Weerasinghe, Amila A; Elmas, Abdulkadir A; Liu, Ruiyang R; Wu, Yige Y; Wendl, Michael C MC; Wyczalkowski, Matthew A MA; Baral, Jessika J; Sengupta, Sohini S; Lai, Chin-Wen CW; Ruggles, Kelly K; Payne, Samuel H SH; Raphael, Benjamin B; Fenyö, David D; Chen, Ken K; Mills, Gordon G; Ding, Li L
Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up.
Bmc Cancer
Kim, Tae-Min TM; Yoo, Jin-Seon JS; Moon, Hyong Woo HW; Hur, Kyung Jae KJ; Choi, Jin Bong JB; Hong, Sung-Hoo SH; Lee, Ji Youl JY; Ha, U-Syn US
mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.
Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer.
The Journal Of Experimental Medicine
Hedberg, Matthew L ML; Peyser, Noah D ND; Bauman, Julie E JE; Gooding, William E WE; Li, Hua H; Bhola, Neil E NE; Zhu, Tian Ran TR; Zeng, Yan Y; Brand, Toni M TM; Kim, Mi-Ok MO; Jordan, Richard C K RCK; VandenBerg, Scott S; Olivas, Victor V; Bivona, Trever G TG; Chiosea, Simion I SI; Wang, Lin L; Mills, Gordon B GB; Johnson, Jonas T JT; Duvvuri, Umamaheswar U; Ferris, Robert L RL; Ha, Patrick P; Johnson, Daniel E DE; Grandis, Jennifer R JR
A Landscape of Pharmacogenomic Interactions in Cancer.
Cell
Iorio, Francesco F; Knijnenburg, Theo A TA; Vis, Daniel J DJ; Bignell, Graham R GR; Menden, Michael P MP; Schubert, Michael M; Aben, Nanne N; Gonçalves, Emanuel E; Barthorpe, Syd S; Lightfoot, Howard H; Cokelaer, Thomas T; Greninger, Patricia P; van Dyk, Ewald E; Chang, Han H; de Silva, Heshani H; Heyn, Holger H; Deng, Xianming X; Egan, Regina K RK; Liu, Qingsong Q; Mironenko, Tatiana T; Mitropoulos, Xeni X; Richardson, Laura L; Wang, Jinhua J; Zhang, Tinghu T; Moran, Sebastian S; Sayols, Sergi S; Soleimani, Maryam M; Tamborero, David D; Lopez-Bigas, Nuria N; Ross-Macdonald, Petra P; Esteller, Manel M; Gray, Nathanael S NS; Haber, Daniel A DA; Stratton, Michael R MR; Benes, Cyril H CH; Wessels, Lodewyk F A LFA; Saez-Rodriguez, Julio J; McDermott, Ultan U; Garnett, Mathew J MJ
Publication Date: 2016-07-28
Variant appearance in text: PIK3CA: 1088G>C; G363A
Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B
Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Nature Medicine
Xie, Mingchao M; Lu, Charles C; Wang, Jiayin J; McLellan, Michael D MD; Johnson, Kimberly J KJ; Wendl, Michael C MC; McMichael, Joshua F JF; Schmidt, Heather K HK; Yellapantula, Venkata V; Miller, Christopher A CA; Ozenberger, Bradley A BA; Welch, John S JS; Link, Daniel C DC; Walter, Matthew J MJ; Mardis, Elaine R ER; Dipersio, John F JF; Chen, Feng F; Wilson, Richard K RK; Ley, Timothy J TJ; Ding, Li L
A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma.
Molecular Cancer Therapeutics
Mazumdar, Tuhina T; Byers, Lauren A LA; Ng, Patrick Kwok Shing PK; Mills, Gordon B GB; Peng, Shaohua S; Diao, Lixia L; Fan, You-Hong YH; Stemke-Hale, Katherine K; Heymach, John V JV; Myers, Jeffrey N JN; Glisson, Bonnie S BS; Johnson, Faye M FM
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.
Cancer Discovery
Lui, Vivian W Y VW; Hedberg, Matthew L ML; Li, Hua H; Vangara, Bhavana S BS; Pendleton, Kelsey K; Zeng, Yan Y; Lu, Yiling Y; Zhang, Qiuhong Q; Du, Yu Y; Gilbert, Breean R BR; Freilino, Maria M; Sauerwein, Sam S; Peyser, Noah D ND; Xiao, Dong D; Diergaarde, Brenda B; Wang, Lin L; Chiosea, Simion S; Seethala, Raja R; Johnson, Jonas T JT; Kim, Seungwon S; Duvvuri, Umamaheswar U; Ferris, Robert L RL; Romkes, Marjorie M; Nukui, Tomoko T; Kwok-Shing Ng, Patrick P; Garraway, Levi A LA; Hammerman, Peter S PS; Mills, Gordon B GB; Grandis, Jennifer R JR